Oncology Central

Prostate cancer deaths are not prevented by one-off PSA screening

Recently published in the Journal of the American Medical Association, researchers at the University of Bristol and the University of Oxford (both UK) have demonstrated that inviting men with no symptoms to a one-off prostate specific antigen (PSA) test for prostate cancer does not save lives.

The study, led by Richard Martin (University of Bristol), included approximately 600 GP practices in the UK with more than 400,000 men aged 50–69. The trial compared 189,386 men who were invited to have a one-off PSA test with 219,439 who were not invited for screening.

After an average of 10 years follow-up, there were 8054 (4.3%)

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.